| Myosarcoma studied in …STUDIED_INderived200 of 325show all (up to 200) |
|---|
| → studied in | NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06865664Phase 1 · recruiting FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06308419Phase 1 · active not recruiting A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830667Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031677Phase 3 · recruiting Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567435Phase 3 · active not recruiting Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Alveolar Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05099666Phase 1/Phase 2 · active not recruiting Lurbinectedin + Doxorubicin In Leiomyosarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516925Phase 2 · recruiting A Study of Ivonescimab in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07054944not yet recruiting Tumor-Lymph Node Mapping · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05304585Phase 3 · recruiting Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Embryonal Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06975293Phase 1/Phase 2 · recruiting STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466316Phase 3 · recruiting A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514819NA · recruiting Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172958Phase 1 · recruiting Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03851614Phase 2 · active not recruiting Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715191Phase 1 · recruiting Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Inflammatory Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554914Phase 2 · active not recruiting A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628634early Phase 1 · recruiting Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07633756Phase 1 · recruiting A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994132Phase 3 · active not recruiting A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Alveolar Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07734805active not recruiting Radiological Diagnosis of Pediatric Neck Swellings · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05227326Phase 1 · recruiting AOH1996 for the Treatment of Refractory Solid Tumors · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721689Phase 1/Phase 2 · recruiting PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04299113Phase 1 · active not recruiting Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624178Phase 2 · active not recruiting A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796543NA · recruiting Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635632Phase 1 · active not recruiting C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925089recruiting Localized Leiomyosarcoma Biomarker Protocol · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05653388recruiting Metastatic Leiomyosarcoma Biomarker Protocol · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088290Phase 3 · active not recruiting Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571734Phase 2 · recruiting XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871766Phase 2 · active not recruiting Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06023641Phase 2 · recruiting Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957431Phase 1 · recruiting Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04796012Phase 1/Phase 2 · recruiting VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457829Phase 2 · recruiting Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04807816Phase 2 · completed Targeting ATR in Soft-tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094101Phase 1/Phase 2 · recruiting Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03054792Phase 1 · enrolling by invitation Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836571Phase 2 · active not recruiting Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516353NA · not yet recruiting my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566092Phase 1 · active not recruiting Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02945800Phase 2 · completed Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383119Phase 2 · recruiting Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Ovarian Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03478462Phase 1 · active not recruiting Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04890093Phase 1/Phase 2 · suspended Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033288recruiting Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Pelvic Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103631Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186992Phase 2 · active not recruiting Radiation Therapy to Treat Musculoskeletal Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016819Phase 3 · recruiting Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709495Phase 1/Phase 2 · recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055220NA · recruiting Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148050Phase 1 · recruiting Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222735Phase 1 · recruiting Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03296371active not recruiting Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Alveolar Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415816NA · completed Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071209Phase 1/Phase 2 · active not recruiting Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Alveolar Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995003Phase 1 · recruiting HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04377932Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07355855Phase 2 · not yet recruiting A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849986Phase 2 · recruiting IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858168Phase 1 · completed Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526679Phase 1/Phase 2 · completed Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04388839Phase 2 · active not recruiting Evolutionary Therapy for Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521567Phase 1/Phase 2 · active not recruiting A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224568Phase 1 · not yet recruiting Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06198296Phase 1 · recruiting Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508038Phase 1 · recruiting Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528769Phase 2 · recruiting Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899805Phase 2 · completed A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080790Phase 2 · completed Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530487Phase 2 · terminated Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00592592NA · completed Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269355Phase 2/Phase 3 · terminated A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06875700recruiting Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05427461NA · active not recruiting Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01793168recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04811196Phase 1 · completed A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898755completed Collecting and Storing Tissue From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06932861early Phase 1 · not yet recruiting Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06924463recruiting Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02100891Phase 2 · terminated Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03496402NA · active not recruiting Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05166577Phase 1 · terminated Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | EBV-Related Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05697198completed PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02428192Phase 2 · completed Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535271Phase 2 · recruiting Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04095221Phase 1/Phase 2 · completed A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04213794early Phase 1 · terminated Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836492Phase 3 · recruiting A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586104NA · completed Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816771Phase 2 · recruiting Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03382158recruiting International PPB/DICER1 Registry · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Embryonal Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03709680Phase 2 · active not recruiting Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076906Phase 1 · completed MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04791228Phase 2 · withdrawn A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05302921Phase 2 · completed Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06684327Phase 2 · recruiting Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01956084Phase 1 · completed Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996004Phase 2 · terminated A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06669013Phase 3 · recruiting Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Embryonal Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Pleomorphic Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521060not yet recruiting The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02509598Phase 2 · completed A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06456892Phase 1/Phase 2 · recruiting Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05093322Phase 1/Phase 2 · completed A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926936Phase 2 · completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625907Phase 1/Phase 2 · recruiting FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02624388Phase 2 · terminated Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386619Phase 1/Phase 2 · completed NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03761095Phase 1 · completed A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03462888unknown Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06244251NA · active not recruiting Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · condition mapped ALIAS · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661400Phase 1 · completed Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336803Phase 2 · completed Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02940041terminated Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06170177recruiting Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Bladder Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116683Phase 2 · terminated ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03458728Phase 1/Phase 2 · terminated Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048371Phase 2 · completed SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05094804Phase 1/Phase 2 · unknown A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02644460Phase 1 · completed Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02304458Phase 1/Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03420014Phase 2 · unknown Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919269completed Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02095132Phase 1/Phase 2 · completed Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05174455Phase 2 · withdrawn Niraparib for the Treatment of Leiomyosarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029465not yet recruiting Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02536183Phase 1 · terminated A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958580NA · terminated Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854018Phase 4 · completed Indo-cyanine Green (ICG) in Paediatric Oncology MIS · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03718091Phase 2 · completed M6620 (VX-970) in Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02822495no longer available Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02275286Phase 1/Phase 2 · recruiting Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Childhood Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730349Phase 1/Phase 2 · terminated A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548179unknown Exploring Clinical Trial Experiences of People With Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890758Phase 1 · completed Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04956198completed Drug Sensitivity and Mutation Profiling · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03655587NA · completed Impact of an Orthotic Intervention in Children With Peripheral Neuropathy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708391Phase 2 · unknown Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354835Phase 3 · completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Adult Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959033terminated Patient Reported Outcome Measures (PROMs) With Trabectedin · condition mapped ONTOLOGY_EXACT · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 325 trials mapped (121 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |